- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 93,130 | 23.07.24 13:05:50 | +0,240 | +0,26% | 93,190 | 93,250 | 93,430 | 92,890 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 985,400 | 23.07.24 12:51:50 | +15,400 | +1,59% | 978,600 | 984,600 | 975,200 | 970,000 |
